반응식
C[O:2][C:3]1[CH:8]=[CH:7][C:6]([C:9]2([CH2:15][N:16]3[CH2:21][CH2:20][O:19][CH2:18][CH2:17]3)[CH2:14][CH2:13][O:12][CH2:11][CH2:10]2)=[CH:5][CH:4]=1.C[S-].[Na+]>>[N:16]1([CH2:15][C:9]2([C:6]3[CH:5]=[CH:4][C:3]([OH:2])=[CH:8][CH:7]=3)[CH2:14][CH2:13][O:12][CH2:11][CH2:10]2)[CH2:17][CH2:18][O:19][CH2:20][CH2:21]1참가 물질
3
실험 절차
The title compound (1.70 g, 75%) was prepared using 4-{[4-(4-methoxyphenyl)tetrahydro-2H-pyran-4-yl]methyl}-morpholine and sodium thiomethoxide similarly to the procedure used for intermediate 72. HRMS ESI+ m/z 278.1740 [MH]+.
출처 및 근거
- ORD 기록
- ord-8d60cee9cf3c4124ad075c7a0c43ad50
- 출처 데이터셋
- uspto-grants-2008_11
- 특허 번호
- US07456164B2
연결된 노트
불러오는 중…